Unique Blood Pumps Inspired By Nature. CorWave is a clinical-stage company with the mission to expand the use of cardiac assist devices to tackle heart failure.
Louis-Emmanuel Le Duc De Lillers · Directeur Général · decision-maker
Gerard Hascoet · Président du conseil d’administration · decision-maker
No careers mailbox known
Sep 17
Hiring 1 new role in 14 days
May 29
Certified CorWave Achieves Major Regulatory Milestone with ISO 13485 Certification Across its Entire Operations · morningstar.com
Apr 2, 2025
New executive CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production · FinanzNachrichten.de
Jun 19, 2023
Raised a round Series C $65.9M
Dec 1, 2011
Founded per the company register
CVRx is a commercial stage, public (NASDAQ: CVRX) medical devices company located in Minneapolis, Minnesota. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. Barostim™ triggers carotid baroreceptors - the body's own natural blood flow regulation system - which signals the brain to regulate cardiovascular function.
No named decision-maker yet.
Careers mailbox is known
Sep 29
Posted 7 roles Production Operator - Medical Device Assembly (on-site), Senior Clinical Specialist - MedTech (Tallahassee, Jacksonville, Pensacola)
Neurona is developing cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases.
James Stutz · Executive Officer · decision-maker
Cory Nicholas · Executive Officer, Director · decision-maker
Tim Kutzkey · Director · decision-maker
Peter Svennilson · Director
Careers mailbox is known
Mar 28, 2025
Raised a round Venture round $101.7M · SEC Form D
New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
Jean Duvall · Chief Executive Officer · decision-maker
Careers mailbox is known
Mar 20
Board appointment REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD · The Manila Times
2021
Founded
About us. Our Leadership team is composed of seasoned professionals with a strong expertise in the orphan diseases and gene therapy field.
Jean-Philippe Combal · Président du conseil d’administration, Président de SAS · decision-maker
Careers mailbox is known
Dec 13, 2017
Increased its share capital $90k · BODACC
Jul 1, 2016
Founded per the company register
Explore Valuat's commitment to reshaping the landscape of private markets in Europe. Our strong founding team pioneers efficient software solutions and financial services, addressing the complexities of diverse regions, regulations, and business scenarios.
No named decision-maker yet.
Careers mailbox is known
Protein Splicing to Develop the Next Generation of Genetic Medicines.
No named decision-maker yet.
Careers mailbox is known
Jan 6
New executive SpliceBio Appoints Don Munoz as Chief Financial Officer · splice.bio
First-in-class ADCs tailored to attack advanced cancer.. Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer.
No named decision-maker yet.
Careers mailbox is known
2019
Founded
About VarmX OUR MISSION To revolutionize the treatment of severe bleeding through a fast, safe, and effective medicine VarmX's VMX-C001 is being developed to facilitate the fast, safe, and effective treatment of severe bleeds in patients that are taking Factor Xa DOACS.
No named decision-maker yet.
Careers mailbox is known
Sep 15
Recognition VarmX recognised with two prestigious industry award nominations · varmx.com
Jan 8
Partnership VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization · varmx.com
May 25, 2023
Raised a round Series B $32.4M
Mar 8, 2023
New executive VarmX Appoints Dr. Jeffrey Lawson, MD, PhD as Chief Scientific Officer · DutchNews.nl
Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
No named decision-maker yet.
Careers mailbox is known
Abbott develops life-changing medical devices for cardiovascular conditions.
No named decision-maker yet.
No careers mailbox known
Transformative Vascular & Valve Implants.
No named decision-maker yet.
Careers mailbox is known
Sep 21
Hiring 1 closed in 14 days
Jul 28
Raised a round Venture round $22.1M
Apr 21
Launched Xeltis releases groundbreaking new 12-month EU pivotal data for aXess demonstrating the transformative potential in hemodialysis treatment · xeltis.com
Apr 21
Certified Xeltis receives CE mark for aXess, its aXess hemodialysis conduit, as it moves to commercialization · manilatimes.net
Jul 23, 2024
New executive Xeltis appoints Shawn Gage as Vice President of US Clinical Affairs · PRNewswire
Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
No named decision-maker yet.
Careers mailbox is known
May 31, 2023
Certified Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy · minoryx.com
Nov 9, 2022
Partnership Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe · minoryx.com
May 30, 2022
Raised a round Venture round $55.1M
Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone.
No named decision-maker yet.
Careers mailbox is known
Sep 29
Closed a role Senior Director, Scientific Communications & Medical Communications
Sep 28
Closed 6 roles Territory Manager - Morristown, NJ, Territory Manager - Los Angeles, CA · reopened Territory Manager - Milwaukee, WI · Director, Compliance crossed 90 days open
Sep 25
Posted a role, closed 3 Director, HCP Marketing · Senior Director, Scientific Communications & Medical Communications crossed 45 days open
Sep 22
Posted 6 roles, closed 12 Territory Manager - Yonkers, NY, Sr. Manager, Compliance Operations
47 open
+1 this week
closes in 69 d market 25
$181k stated pay, 48 roles
truth A 89
